Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04392843 · ClinicalTrials.gov registry record · NA
Effect of Fasting on Insulin-induced Hypoglycemia Counterregulation in Healthy Humans
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04392843 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 12 participants.
The verdict
NCT04392843, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Iatrogenic hypoglycemia is still considered to be the number one barrier to effective glycemic control in patients with type 1 diabetes (T1D). In a previous study, we observed in dogs that liver glycogen content can be a determinant of hormonal and hepatic responses to insulin-induced hypoglycemia. In the experiments described herein, we will determine if nutritionally-manipulated changes in liver glycogen concentrations have an impact on hypoglycemic counterregulation in non-T1D control subjects.
Interventions
- OTHER Fasting
- OTHER Feeding
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-04-12 |
| Est. Completion | 2023-05-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04392843
The ClinicalTrials.gov registry entry for NCT04392843 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fasting is the first listed.
NCT04392843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04392843 about?
NCT04392843 is a clinical study titled "Effect of Fasting on Insulin-induced Hypoglycemia Counterregulation in Healthy Humans". Iatrogenic hypoglycemia is still considered to be the number one barrier to effective glycemic control in patients with type 1 diabetes (T1D). In a previous study, we observed in dogs that liver glycogen content can be a determinant of hormonal and hepatic responses to insulin-induced hypoglycemia. ...
What is the current status of trial NCT04392843?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2019-04-12. Estimated completion is 2023-05-11.
What interventions are being tested in trial NCT04392843?
The interventions under investigation include: Fasting (OTHER), Feeding (OTHER).
Who is sponsoring clinical trial NCT04392843?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.